Press release
Intravitreal (IVT) Injectable Market is Expected to Reach US$ 26,526.1 Million by 2034 | Fact.MR Study
Intravitreal (IVT) Injectable Market
The intravitreal injectables demand is increasing as a result of improved pharmaceutical delivery technologies and a rise in the incidence of eye diseases. The aging population and the increasing demand for low-risk, effective therapies are driving the intravitreal (IVT) injectable market growth.
The creation of sustained-release implants, biodegradable microspheres, and smart drug delivery systems is driving growth in the intravitreal (IVT) injectable market. These innovations are designed to enhance medication efficacy, reduce the frequency of injections, and enhance patient compliance.
Technological improvements in targeted therapies and personalized medicine, which allow precise and effective treatment of eye diseases, are also aiding the market's growth. Enhanced research and development activities to explore new treatment options and expand the indications for IVT injectables are also contributing to the mounting market value.
For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=9541
Key Takeaways from Market Study:
The estimated market value for the intravitreal injectable market in 2024 is projected to reach US$ 17,565.4 million, highlighting the growing demand for these treatments in ophthalmology.
By 2034, the forecasted market value is expected to rise to US$ 26,526.1 million, reflecting a steady expansion driven by increasing cases of retinal diseases and advancements in injectable therapies.
The global market growth rate from 2024 to 2034 is anticipated to be 4.2%, indicating consistent demand and the adoption of innovative treatment solutions across various regions.
The corticosteroids segment is set to experience a robust growth rate of 5.1% during the forecast period, driven by its effectiveness in treating inflammatory eye conditions and reducing vision loss risks.
The retinal vein occlusions segment is expected to grow at a rate of 4.7% from 2024 to 2034, supported by the rising prevalence of vascular disorders affecting the retina and an increasing number of aging populations.
North America's market share in 2024 stands at 3.4%, signifying its role as a key player in the industry due to advanced healthcare infrastructure, high patient awareness, and significant research investments.
East Asia's market share in 2024 is estimated at 6.6%, demonstrating the region's rapid expansion fueled by growing healthcare access, increasing disposable income, and rising cases of diabetic retinopathy and macular degeneration.
Leading Players Driving Innovation in the Intravitreal (IVT) Injectable Market:
Regeneron Pharmaceuticals, Inc.; Bausch & Lomb; Novartis AG; Allergan; Alimera Sciences; ThromboGenics, Inc.; Bristol-Myers Squibb Company; Other
Which are the Aspects Driving the Expansion of the Intravitreal Injectable Market?
"Development of Targeted Therapies and Personalized Medicines"
Sustained-release implants, biodegradable microspheres, and intelligent drug delivery systems are driving the expansion of the market. These are behind enhanced medication effectiveness, reduced injection frequency, and enhanced patient compliance.
The evolution of targeted drugs and personalized medicine and the use of combination therapies are driving the demand for intravitreal injectables. Increasing emphasis on R&D to explore new treatment options are strengthening the growth of the market.
Browse Full Report: https://www.factmr.com/report/intravitreal-injectable-market
Country-wise Analysis:
The North America intravitreal (IVT) injectable market is poised to grow at a CAGR of 3.4% through 2034. The key driver behind the surge is the growing need for IVT injectables across key markets, especially the United States and Canada. Through 2034, the United States will hold the dominant share of 92.4% of the regional market.
The East Asian IVT injectable market is anticipated to grow at a strong CAGR of 6.6% during the period 2034. The most profitable market in East Asia is China, with a share of 47.9%. The increasing importance and geographical diversity of the market are anticipated to create substantial opportunities for established players and new entrants.
More Valuable Insights on Offer:
Fact.MR, in its new offering, presents an unbiased analysis of the global intravitreal (IVT) injectable market, presenting historical data for 2020 to 2024 and forecast statistics for 2025 to 2035.
The study reveals essential insights on the basis of the drug class, indication, distribution channel, and region. By drug class, the market includes Anti-VEGF, Corticosteroids, Antibiotics, Antivirals, and Antifungal treatments.
In terms of indication, the market is categorized into Diabetic Retinopathy, Macular Degeneration, Endophthalmitis, Retinal Vein Occlusions, and other related conditions. The distribution channel segment comprises Hospital Pharmacies, Retail Pharmacies, Drug Stores, Mail Order Pharmacies, and other channels. Regionally, the market is analyzed across North America, East Asia, South Asia and Pacific, Western Europe, Eastern Europe, and the Middle East and Africa.
Check out More Related Studies Published by Fact.MR:
Injectable Drug Delivery Market - https://www.factmr.com/report/injectable-drug-delivery-market
Sterile Injectable Drug Market - https://www.factmr.com/report/sterile-injectable-drug-market
Generic Injectables Market - https://www.factmr.com/report/4681/generic-injectables-market
Injection Pen Market - https://www.factmr.com/report/5212/injection-pen-market
Injectable Bone Graft Substitute Market - https://www.factmr.com/report/1272/injectable-bone-graft-substitutes-market
Contact:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Sales Team: sales@factmr.com
Follow Us: LinkedIn | Twitter | Blog
Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Intravitreal (IVT) Injectable Market is Expected to Reach US$ 26,526.1 Million by 2034 | Fact.MR Study here
News-ID: 3949099 • Views: …
More Releases from Fact.MR Market Research
Undecylenic Acid Market Is Expected To Grow At A CAGR Of 4% During The Forecast …
Undecylenic acid, an unsaturated fatty acid derived from castor oil, is recognized for its antifungal properties. It is widely used in medical treatments for skin infections, as well as in the production of cosmetics and personal care products. The market is projected to witness higher single-digit growth globally during the forecast period, with regions like North America and Europe leading in volume, while the Middle East and Africa (MEA) are…
Whey Cheese Market to Reach USD 21.6 Billion by 2035 Amid Rising Demand for Func …
The global whey cheese market is witnessing remarkable growth, driven by increasing consumer preference for protein-rich, functional, and sustainable dairy products. According to recent research, the market is expected to reach USD 21.6 billion by 2035, up from USD 10.5 billion in 2024, marking a robust compound annual growth rate (CAGR) of 6.8% during the forecast period from 2025 to 2035.
Rising Demand for Functional and Protein-Rich Foods Fuels Market Expansion
The…
Enzyme-Enhanced Ingredients Market to Reach USD 11,657 Million by 2035, Driven b …
The global enzyme-enhanced ingredients market is poised for remarkable growth, with the industry projected to reach USD 11,657 million by 2035, up from USD 5,955 million in 2024. This expansion is expected to occur at a robust compound annual growth rate (CAGR) of 6.5% between 2025 and 2035.
The surge in demand is primarily driven by the rising adoption of enzyme-based solutions across food, beverage, and nutraceutical industries, alongside an…
Glycine Market Set to Reach USD 2,825.8 Million by 2035, Driven by Expanding App …
The global glycine market is poised for remarkable growth over the next decade, with market value projected to surge from USD 1,356.4 million in 2024 to USD 2,825.8 million by 2035.
During the forecast period from 2025 to 2035, the industry is expected to expand at a robust CAGR of 6.9%, reflecting the increasing demand for this versatile amino acid across multiple end-use sectors. Glycine, the simplest amino acid, is…
More Releases for IVT
Intravitreal (IVT) Injectable Market Dynamics: Driving Forces Behind Market Expa …
The healthcare sector, especially in the field of ophthalmology, is witnessing significant growth due to the rising prevalence of eye diseases and advancements in injectable drug delivery systems. One of the most important developments in the treatment of retinal diseases has been the introduction of intravitreal (IVT) injectables. These injectable therapies are used to treat a range of eye conditions, such as age-related macular degeneration (AMD), diabetic retinopathy (DR), diabetic…
Intravitreal (IVT) Injectable Market Transformative Innovations and Future Growt …
𝑰𝒏𝒕𝒓𝒐𝒅𝒖𝒄𝒕𝒊𝒐𝒏
The Intravitreal (IVT) injectable market has emerged as a pivotal segment in ocular therapeutics, driven by the increasing prevalence of retinal disorders and advancements in drug delivery technologies. Intravitreal injections, administered directly into the vitreous humor, have revolutionized the treatment of various ocular conditions such as age-related macular degeneration (AMD), diabetic macular edema (DME), and retinal vein occlusion (RVO). This article explores the transformative innovations shaping the IVT injectable market…
Intravitreal (IVT) Injectable Market Size, Share, Industry, Forecast (2024-2031)
Market Overview:
The global intravitreal injectable market is growing at a CAGR of 5.8% during the forecast period of 2024-2031. Key drivers of market growth include the increasing prevalence of chronic retinal diseases, particularly cataracts, and advancements in drug development by key manufacturers to meet patient needs. However, market growth may be hindered by the risks associated with intravitreal injections.
Market Dynamics:
Growing Prevalence of Cataracts: Cataracts, which are the primary cause of…
The Intravitreal (IVT) Injectable Market To Prove Its Servility To Technological …
According to the most recent Persistence Market Research (PMR) report, the Intravitreal (IVT) Injectables Market will grow at a CAGR of 4.9% between 2022 and 2028, surpassing US$ 23,814.3 million in terms of market value.
Growing retinal diseases are expected to boost the global intravitreal injectable market at a substantial rate over the forecast period. Millions of people are affected by retinal disorders, which commonly result in vision loss or complete…
The Intravitreal IVT Injectable Market to Witness Invigorating Trends
The Intravitreal IVT Injectable Market is expected to grow on an irreversible note in the next 10 years. The future scenario would be data-driven healthcare. This would, in turn, widen the potential for enhancing treatment options. With interoperability taking the centre stage, program participants could access app blueprints, data templates, and security tools. Thus, the big data cloud would turn out to be kinetic. This would result in an upswing…
The Intravitreal IVT Injectable Market to grow on an invincible note
The Intravitreal IVT Injectable Market is expected to grow by leaps and bounds in the forecast period. Nanotechnology’s medical application is on the anvil. As such, nanomedicine is an outcome of the technology operating at the molecular, atomic, or supramolecular scale. The broad application areas of nanomedicine include sensing, imaging, diagnosis, and delivery via medical devices. This would certainly keep the healthcare vertical upgraded continuously.
Hereditary retinal diseases is the major…
